PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 129 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2020. The put-call ratio across all filers is 2.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $829,000 | -24.2% | 80,823 | -25.5% | 0.00% | -50.0% |
Q3 2020 | $1,094,000 | -79.2% | 108,463 | -78.5% | 0.00% | -80.0% |
Q2 2020 | $5,258,000 | +966.5% | 504,167 | +763.3% | 0.01% | +900.0% |
Q1 2020 | $493,000 | -64.0% | 58,400 | -62.7% | 0.00% | -66.7% |
Q4 2019 | $1,370,000 | – | 156,599 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 200,000 | $20,706,000 | 6.01% |
Redmile Group, LLC | 230,673 | $23,882,000 | 2.95% |
WEATHERBIE CAPITAL, LLC | 241,419 | $24,994,000 | 2.31% |
Tekla Capital Management LLC | 185,820 | $19,238,000 | 2.02% |
Ghost Tree Capital, LLC | 25,000 | $2,588,000 | 1.59% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $588,741,000 | 1.56% |
Iguana Healthcare Management, LLC | 25,000 | $2,588,000 | 1.48% |
Eventide Asset Management | 42,100 | $4,359,000 | 1.34% |
Bain Capital Public Equity Management, LLC | 401,330 | $41,550,000 | 1.17% |
Rock Springs Capital Management LP | 31,500 | $3,261,000 | 1.16% |